SBIR/STTR Research Award

Durable Visible Light-activated Antiviral Coatings for Fabrics Used for Personal

Award identifier 510150b205a366e8ce959a7787909f0be80ca126e33529ca22a2dd7962e27d4fAwarding agency Department of Health and Human Services · Centers for Disease Control and Prevention

Award amount

$100,000

Program and phase

SBIR · Phase I

Award year

2008

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Centers for Disease Control and Prevention
Recipient company
LAAMSCIENCE, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Influenza and other enveloped viruses are responsible for hundreds of thousands of deaths worldwide each year and cost the US economy over 70 billion each year in medical costs and lost work. A new approach to preventi ng the spread of viral infections in general, and influenza in particular, would be of benefit. Influenza enters the body through the nose or throat. NIOSH estimates that 90 million N95 filtering faceplate respirators will be needed to protect workers in t he healthcare sector alone during a 42-day outbreak, likely requiring re-use of respirators. Opportunities exist for simple, efficacious decontamination methods that reduce the risk of infection through handling a contaminated respirator and that do not co mpromise respirator effectiveness. Using our proprietary technology, LaamScience is developing coatings useful for a durable, self-regenerating, and cost- effective N95 mask with a broad spectrum of viral inactivation. Importantly, the mechanism of inactiv ation will not lead to microbial resistance. We are developing a fiber treatment using photoactive dyes that inactivate enveloped viruses upon illumination with visible light. Candidate dyes have been chosen that generate the most singlet oxygen [the activ e antiviral agent] per unit light intensity for light sources simulating solar, incandescent, and fluorescent lighting. We propose to modify air filtration textiles with these dye coatings and test efficacy to significantly inactivate influenza viruses tra pped on the face mask fiber. The objective of this phase I feasibility project is to develop effective, stable dye-carrier combinations that will provide inexpensive filtration textiles with high antiviral activity. Dye-carrier combinations will be optimiz ed to preserve dye activity upon attachment to the carrier. Coating or Finishing methods will be defined for applying the photoactive dye-carrier combinations to air filtration surfaces that allow maximum singlet oxygen generation / antiviral activity. T he efficacy of modified surfaces will be determined by dosing the surfaces with virus, exposing them to selected light intensities, temperature, and humidity conditions and assaying the rate and extent of viral inactivation. Milestones are: 1] Select the m ost cost-effective dye-carrier combinations that retain the highest level of singlet oxygen production and antiviral activity; 2] Develop an efficient, scaleable attachment method to retain maximum antiviral activity; 3] Determine coating stability and eff ectiveness under likely conditions of use. For commercialization the optimized coatings must inactivate more than 99.9% of a challenge inoculum of influenza virus within one hour under typical conditions of use. Our long-term objective is to use these coat ed fabrics to produce personal protective equipment capable of inactivating microorganisms, reducing the bioburden on these items and reducing the potential for disease transmission. PUBLIC HEALTH RELEVANCE Masks and respirators are intended to reduce the wearer's exposure to small airborne particles including bacteria, fungi, and viruses. The goal of the research is to determine feasibility of attaching a microbe- inactivating coating to material used in masks, thereby reducing the microbe burden on the ma sk surface and making it less likely that a user would contaminate their hands with active organisms when handling the mask. Ultimately this treatment will be incorporated into other personal protective equipment for first responders, healthcare personnel, and other essential workers to help reduce the incidence of infectious disease.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.